Oksana Kehoe
Oswestry, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
GRAPPA 2025 Annual Meeting: Advances in Psoriatic Disease Research From Pilot Grant Awardees.
Journal: The Journal of rheumatology
Published: April 13, 2026
Donor Pooling as an Effective Method to Increase MSC EV Production Without Compromising Therapeutic Potential.
Journal: Journal of extracellular biology
Published: October 14, 2025
Extracellular vesicle bioactivity and potential for clinical development are determined by mesenchymal stromal cell clonal subtype.
Journal: Stem cell research & therapy
Published: April 11, 2025
ST2-Conditioned Medium Fosters Dorsal Horn Cell Excitability and Synaptic Transmission in Cultured Mouse Spinal Cord.
Journal: Stem cell reviews and reports
Published: August 28, 2023
Extracellular vesicles derived from umbilical cord mesenchymal stromal cells show enhanced anti-inflammatory properties via upregulation of miRNAs after pro-inflammatory priming.
Journal: Stem cell reviews and reports
Published: July 03, 2023
Extracellular Vesicle Depletion Protocols of Foetal Bovine Serum Influence Umbilical Cord Mesenchymal Stromal Cell Phenotype, Immunomodulation, and Particle Release.
Journal: International journal of molecular sciences
Published: March 27, 2023
Psoriatic arthritis: review of potential biomarkers predicting response to TNF inhibitors.
Journal: Inflammopharmacology
Published: July 20, 2022
Therapeutic Effects of Hypoxic and Pro-Inflammatory Priming of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Inflammatory Arthritis.
Journal: International journal of molecular sciences
Published: November 27, 2021
Syndecan-3 regulates MSC adhesion, ERK and AKT signalling in vitro and its deletion enhances MSC efficacy in a model of inflammatory arthritis in vivo.
Journal: Scientific reports
Published: February 18, 2020
Soluble syndecan-3 binds chemokines, reduces leukocyte migration in vitro and ameliorates disease severity in models of rheumatoid arthritis.
Journal: Arthritis research & therapy
Published: April 02, 2019
Novel Anti-Inflammatory Peptides Based on Chemokine-Glycosaminoglycan Interactions Reduce Leukocyte Migration and Disease Severity in a Model of Rheumatoid Arthritis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 22, 2017
Last Updated: 09/26/2026